Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02638428 |
|
Recruitment Status :
Recruiting
First Posted : December 23, 2015
Last Update Posted : March 19, 2020
|
Sponsor:
Samsung Medical Center
Collaborator:
Ministry of Health, Republic of Korea
Information provided by (Responsible Party):
Samsung Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2021 |
| Estimated Study Completion Date : | December 2023 |